DNA methylation age acceleration contributes to the development and prediction of non-alcoholic fatty liver disease

[1]  Weiqi Wang,et al.  Identification of circulating sphingosine kinase-related metabolites for prediction of type 2 diabetes , 2021, Journal of translational medicine.

[2]  L. Liang,et al.  Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial , 2021, Clinical epigenetics.

[3]  P. Fariselli,et al.  Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? , 2021, Gut.

[4]  Sijia Wang,et al.  Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR_based lipoprotein profiling. , 2020, Journal of hepatology.

[5]  S. Pluchino,et al.  Parkinson's disease, aging and adult neurogenesis: Wnt/β‐catenin signalling as the key to unlock the mystery of endogenous brain repair , 2020, Aging cell.

[6]  A. Sanyal,et al.  MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. , 2020, Gastroenterology.

[7]  S. Horvath,et al.  Epigenetic age acceleration and metabolic syndrome in the coronary artery risk development in young adults study , 2019, Clinical Epigenetics.

[8]  W. Milberg,et al.  Investigation of bidirectional longitudinal associations between advanced epigenetic age and peripheral biomarkers of inflammation and metabolic syndrome , 2019, Aging.

[9]  Z. Younossi.  Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.

[10]  B. Schumacher,et al.  DNA damage responses and p53 in the aging process. , 2018, Blood.

[11]  Zhaoshi Jiang,et al.  DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis. , 2018, JCI insight.

[12]  Caroline L. Wilson,et al.  Cellular senescence drives age-dependent hepatic steatosis , 2017, Nature Communications.

[13]  Andrew E. Teschendorff,et al.  A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies , 2017, BMC Bioinformatics.

[14]  Robert Blissett,et al.  The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe , 2016, Hepatology.

[15]  D. Figeys,et al.  Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways , 2016, Scientific Reports.

[16]  Jessica M. Lindvall,et al.  Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients , 2016, Molecular metabolism.

[17]  D. Ma,et al.  Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids , 2015, Hepatology.

[18]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[19]  Judith Heaney,et al.  The senescent hepatocyte gene signature in chronic liver disease , 2014, Experimental Gerontology.

[20]  Steve Horvath,et al.  Obesity accelerates epigenetic aging of human liver , 2014, Proceedings of the National Academy of Sciences.

[21]  Andrew E. Teschendorff,et al.  ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..

[22]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[23]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[24]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[25]  Meng-Su Zeng,et al.  Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method , 2011, Obesity.

[26]  A. Hofman,et al.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design , 2010, European Journal of Epidemiology.

[27]  M. Jensen,et al.  Fat tissue, aging, and cellular senescence , 2010, Aging cell.

[28]  M. Zamboni,et al.  Aging and Regional Differences in Fat Cell Progenitors – A Mini-Review , 2010, Gerontology.

[29]  J. Newton,et al.  Non-Alcoholic Fatty Liver Disease in Older People , 2009, Gerontology.

[30]  I. Rusyn,et al.  Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. , 2009, Journal of hepatology.

[31]  Tom Britton,et al.  Dynamics of fat cell turnover in humans , 2008, Nature.

[32]  G. Bray,et al.  Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity , 2008, Expert review of cardiovascular therapy.

[33]  Ji Young Kim,et al.  Differentiation-dependent expression of Adhfe1 in adipogenesis. , 2007, Archives of biochemistry and biophysics.

[34]  F. Hegardt,et al.  Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity. , 2007, American journal of physiology. Endocrinology and metabolism.

[35]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[36]  S. Malnick,et al.  Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[37]  C. Xie,et al.  Polymorphisms in PDLIM5 gene are associated with alcohol dependence, type 2 diabetes, and hypertension. , 2017, Journal of psychiatric research.

[38]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[39]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..